Psychiatry & Mental Health

Arianna Huffington, the founder of Thrive Global, spoke with School of Medicine Dean Lloyd Minor about self-care during the pandemic.

A common genetic deletion boosts the risk for schizophrenia by 30-fold. Generating nerve cells from people with the deletion has showed Stanford researchers why.

Cerebrospinal fluid levels of a hormone called vasopressin were lower in babies who went on to develop autism than in those who did not, a study found.

Signals from the brain’s fear center make it more difficult for anxious and stressed children to regulate their emotions, a first-of-its-kind brain scanning study from Stanford shows.

Stanford Medicine researchers have found a gene variant that protects carriers of another gene variant, ApoE4, from developing Alzheimer’s disease — the first demonstration of that beneficial effect.

Researchers used electroencephalography and artificial intelligence to identify individuals who would likely respond to sertraline, the antidepressant marketed as Zoloft.

Stanford experts have created four short videos to help lawyers at the U.S. border learn to sensitively interview migrant children and teens about traumatic experiences.

Jin Hyung Lee will receive $3.5 million to study the use of innovative technology to analyze brain circuitry, and Corey Keller will receive $1.25 million to fund work into brain stimulation treatments for mental illness.

Tapping the interests and motivations of children with autism can help them understand the value of speaking and build their social skills, a new Stanford study found.

Stanford scientists, using only direct brain stimulation, reproduced both the brain dynamics and the behavioral response of mice taught to discriminate between two different images.

Physicians and patients are excited about ketamine, the latest drug to treat depression, but Stanford psychiatrist Alan Schatzberg says we need to tread carefully.